These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38890748)

  • 1. Trial participants' self-reported understanding of randomisation phrases in participation information leaflets can be high, but acceptability of some descriptions is low, especially those linked to gambling and luck.
    Shiely F; Murphy E; Gilles K; Hood K; O'Sullivan L; Harman N; Isaacs T; Treweek S
    Trials; 2024 Jun; 25(1):391. PubMed ID: 38890748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient information leaflets (PILs) for UK randomised controlled trials: a feasibility study exploring whether they contain information to support decision making about trial participation.
    Gillies K; Huang W; Skea Z; Brehaut J; Cotton S
    Trials; 2014 Feb; 15():62. PubMed ID: 24548781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When describing harms and benefits to potential trial participants, participant information leaflets are inadequate.
    Cuddihy L; Howick J; Murphy E; Shiely F
    Trials; 2024 May; 25(1):292. PubMed ID: 38693579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retention strategies are routinely communicated to potential trial participants but often differ from what was planned in the trial protocol: an analysis of adult participant information leaflets and their corresponding protocols.
    Murphy E; Gillies K; Shiely F
    Trials; 2024 Jun; 25(1):372. PubMed ID: 38858790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lay public's understanding of equipoise and randomisation in randomised controlled trials.
    Robinson EJ; Kerr CE; Stevens AJ; Lilford RJ; Braunholtz DA; Edwards SJ; Beck SR; Rowley MG
    Health Technol Assess; 2005 Mar; 9(8):1-192, iii-iv. PubMed ID: 15763039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative importance of informational items in participant information leaflets for trials: a Q-methodology approach.
    Innes K; Cotton S; Campbell MK; Elliott J; Gillies K
    BMJ Open; 2018 Sep; 8(9):e023303. PubMed ID: 30185580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Information about dissemination of trial results in patient information leaflets for clinicals trials in the UK and Ireland: The what and the when.
    Bjorklund M; Shiely F; Gillies K
    PLoS One; 2022; 17(5):e0268898. PubMed ID: 35609047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimising informed consent for participants in a randomised controlled trial in rural Uganda: a comparative prospective cohort mixed-methods study.
    Ditai J; Kanyago J; Nambozo MR; Odeke NM; Abeso J; Dusabe-Richards J; Olupot-Olupot P; Carrol ED; Medina-Lara A; Gladstone M; Storr J; Faragher B; Weeks AD
    Trials; 2018 Dec; 19(1):699. PubMed ID: 30577809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient information leaflets for placebo-controlled surgical trials: a review of current practice and recommendations for developers.
    Cousins S; Huttman M; Blencowe N; Tsang C; Elliott D; Blazeby J; Beard DJ; Campbell MK; Gillies K
    Trials; 2024 May; 25(1):339. PubMed ID: 38778336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of health literacy interventions on the informed consent process of health care users: a systematic review protocol.
    Perrenoud B; Velonaki VS; Bodenmann P; Ramelet AS
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):82-94. PubMed ID: 26571285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A qualitative exploration of trial-related terminology in a study involving Deaf British Sign Language users.
    Young A; Oram R; Dodds C; Nassimi-Green C; Belk R; Rogers K; Davies L; Lovell K
    Trials; 2016 Apr; 17(1):219. PubMed ID: 27121282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nocebo effects and participant information leaflets: evaluating information provided on adverse effects in UK clinical trials.
    Kirby N; Shepherd V; Howick J; Betteridge S; Hood K
    Trials; 2020 Jul; 21(1):658. PubMed ID: 32680561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomisation in trials: do potential trial participants understand it and find it acceptable?
    Kerr C; Robinson E; Stevens A; Braunholtz D; Edwards S; Lilford R
    J Med Ethics; 2004 Feb; 30(1):80-4. PubMed ID: 14872081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Offering patients entry in clinical trials: preliminary study of the views of prospective participants.
    Corbett F; Oldham J; Lilford R
    J Med Ethics; 1996 Aug; 22(4):227-31. PubMed ID: 8863148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Observational Study of the Association of Video- Versus Text-Based Informed Consent With Multicenter Trial Enrollment: Lessons From the PALM Study (Patient and Provider Assessment of Lipid Management).
    Fanaroff AC; Li S; Webb LE; Miller V; Navar AM; Peterson ED; Wang TY
    Circ Cardiovasc Qual Outcomes; 2018 Apr; 11(4):e004675. PubMed ID: 29625993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does different information disclosure on placebo control affect blinding and trial outcomes? A case study of participant information leaflets of randomized placebo-controlled trials of acupuncture.
    Cheon S; Park HJ; Chae Y; Lee H
    BMC Med Res Methodol; 2018 Jan; 18(1):13. PubMed ID: 29347917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Readability and understandability of clinical research patient information leaflets and consent forms in Ireland and the UK: a retrospective quantitative analysis.
    O'Sullivan L; Sukumar P; Crowley R; McAuliffe E; Doran P
    BMJ Open; 2020 Sep; 10(9):e037994. PubMed ID: 32883734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Informed consent and placebo effects: a content analysis of information leaflets to identify what clinical trial participants are told about placebos.
    Bishop FL; Adams AE; Kaptchuk TJ; Lewith GT
    PLoS One; 2012; 7(6):e39661. PubMed ID: 22761859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An enhanced participant information leaflet and multimedia intervention to improve the quality of informed consent to a randomised clinical trial enrolling people living with HIV and obesity: a protocol for a Study Within A Trial (SWAT).
    O'Sullivan L; Savinelli S; O'Hare S; Holden S; McHugh C; Mallon P; Doran P
    Trials; 2022 Jan; 23(1):50. PubMed ID: 35039057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.